Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: Radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities

Urology

Volumn 54, Issue 2, 1999, Pages 313-318

  Akakura, Koichiro ^a   Isaka, Shigeo ^a   Akimoto, Susumu ^a   Ito, Haruo ^a   Okada, Kiyoki ^b   Hachiya, Takahiko ^b   Yoshida, Osamu ^c   Arai, Yoichi ^c   Usami, Michiyuki ^d   Kotake, Toshihiko ^d   Tobisu, Ken Ichi ^e   Ohashi, Yasuo ^f   Sumiyoshi, Yoshiteru ^g   Kakizoe, Tadao ^e   Shimazaki, Jun ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d CENTER FOR ADULT DISEASES   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; LINEAR ACCELERATOR; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; URINE INCONTINENCE;

EID: 0032787203     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00106-5     Document Type: Article

References (31)

1. Gerber G.S., Thisted R.A., Scardino P.T., et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 276:1996;615-619.
2. Epstein J.I., Partin A.W., Sauvageot J., et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 20:1996;286-292.
3. Catalona W.J., Smith D.S. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842.
4. Fowler J.E. Jr, Braswell N.T., Pandey P., et al. Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center. J Urol. 153:1995;1026-1031.
5. Bagshaw M.A., Cox R.S., Hancock S.L. Control of prostate cancer with radiotherapy long-term results . J Urol. 152:1994;1781-1785.
6. Perez C.A., Hanks G.E., Leibel S.A., et al. Localized carcinoma of the prostate (stages T1b, T1c, T2, and T3). Review of management with external beam radiation therapy. Cancer. 72:1993;3156-3173.
7. Mordkin R.M., Hayes W.S., Kuettel M.R., et al. Management of locally advanced prostate cancer. Oncology. 10:1996;1289-1306.
8. van den Ouden D., Davidson P.J.T., Hop W., et al. Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J Urol. 151:1994;646-651.
9. Bruchovsky N. Androgens and antiandrogens. Holland J.F., Frei E. III, Bast R.C. Jr, et al. Cancer Medicine. 1993;884-896 Lea & Febiger, Philadelphia.
10. Scott W.W., Boyd H.L. Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate a retrospective study based upon 25 years of experience . J Urol. 101:1969;86-92.
11. Freeman J.A., Lieskovsky G., Cook D.W., et al. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCN0) prostate cancer from 1976 to 1989 intermediate findings . J Urol. 149:1993;1029-1034.
12. Zagars G.K., Johnson D.E., von Eschenbach A.C., et al. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate long-term results of a prospective randomized study . Int J Radiat Oncol Biol Phys. 14:1988;1985-1991.
13. Isaka S., Shimazaki J., Akimoto S., et al. A prospective randomized trial for treating stages B2 and C prostate cancer radical surgery or irradiation with neoadjuvant endocrine therapy . Jpn J Clin Oncol. 24:1994;218-223.
14. Fossa S.D., Aaronson N.K., Newling D., et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer. 26:1990;1133-1136.
15. Isaka S., Shimazaki J., Akaza H., et al. Assessment of the quality of life of prostate cancer patients. Jpn J Urol. 84:1993;1611-1617.
16. Paulson D.F., Lin G.H., Hinshaw W., et al. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol. 128:1982;502-504.
17. Kupelian P., Katcher J., Levin H., et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores . Cancer J Sci Am. 3:1997;78-87.
18. D'Amico A.V., Whittington R., Kaplan I., et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4-20 ng/ml. Int J Radiat Oncol Biol Phys. 37:1997;1053-1058.
19. Brendler C.B., Cleeve L.K., Anderson E.E., et al. Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit . J Urol. 124:1980;849-850.
20. Smith J.A. Jr, Seaman J.P., Gleidman J.B., et al. Pelvic lymph node metastasis from prostatic cancer influence of tumor grade and stage in 452 consecutive patients . J Urol. 130:1983;290-292.
21. Lee R.J., Sause W.T. Surgically staged patients with prostatic carcinoma treated with definitive radiotherapy fifteen-year results . Urology. 43:1994;640-644.
22. Akakura K., Akimoto S., Ohki T., et al. Radiation therapy for prostate cancer confined to pelvis. Int J Urol. 1:1994;268-272.
23. Swanson G.P., Cupps R.E., Utz D.C., et al. Definitive therapy for prostate carcinoma Mayo Clinic results at 15 years after treatment . Br J Radiol. 67:1994;877-889.
24. Fair W.R., Cookson M.S., Stroumbakis N., et al. The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer Memorial Sloan-Kettering Cancer Center results . Urology. 49:1997;46-55.
25. Middleton R.G., Larsen R.H. Selection of patients with stage B prostate cancer for radical prostatectomy. Urol Clin North Am. 17:1990;779-785.
26. Soloway M.S., Sharifi R., Wajsman Z., et al. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol. 154:1995;424-428.
27. Goldenberg S.L., Klotz L.H., Srigley J., et al. Randomized, prospective controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol. 156:1996;873-877.
28. Witjes W.P.J., Schulman C.C., Debruyne F.M.J., et al. Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostate carcinoma. Urology. 49:1997;65-69.
29. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.
30. Laverdiere J., Gomez J.L., Cusan L., et al. Beneficial effects of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;247-252.
31. Lim A.J., Brandon A.H., Fiedler J., et al. Quality of life radical prostatectomy versus radiation therapy for prostate cancer . J Urol. 154:1995;1420-1425.